Updated Articles for Listserv
Medicare Updated Articles Display Page
| Article ID | Modified By | Modified On | Title |
|---|---|---|---|
| 30019418 | James Marko | 2026-03-25 14:25:17.583 | Healthcare Common Procedure Coding System (HCPCS) Level II Code Compliance Guidance |
| 30019468 | James Marko | 2026-03-25 14:27:09.119 | Billing and Coding Nusinersen, (brand name SPINRAZA®) |
| 30014732 | Kirby Schwartzbauer | 2026-03-24 13:14:04.452 | CMS Releases Updated Advance Beneficiary Notice of Non-coverage (ABN) |
| 30006900 | Kirby Schwartzbauer | 2026-03-20 13:54:24.061 | Intravenous Immune Globulin Items & Services (IVIGs) |
| 30014720 | Kirby Schwartzbauer | 2026-03-24 13:14:29.561 | CMS Releases Updated Advance Beneficiary Notice of Non-coverage (ABN) |
| 30006912 | Kirby Schwartzbauer | 2026-03-20 13:54:31.054 | Intravenous Immune Globulin Items & Services (IVIGs) |
| 30019676 | James Marko | 2026-03-25 14:30:24.076 | Post Market Studies and Post Market Extension Studies - Percutaneous Transluminal Angioplasty (PTA) with Carotid Stenting and Embolic Protection |
| 30019370 | James Marko | 2026-03-25 14:25:19.06 | Healthcare Common Procedure Coding System (HCPCS) Level II Code Compliance Guidance |
| 30019451 | James Marko | 2026-03-25 14:26:32.851 | Billing and Coding Nusinersen, (brand name SPINRAZA®) |
| 30019693 | James Marko | 2026-03-25 14:30:42.874 | Post Market Studies and Post Market Extension Studies - Percutaneous Transluminal Angioplasty (PTA) with Carotid Stenting and Embolic Protection |
| Article ID | Modified By | Modified On | Title |
|---|---|---|---|
| 30014684 | Kirby Schwartzbauer | 2026-03-24 13:13:39.373 | CMS Releases Updated Advance Beneficiary Notice (ABN) |
| Article ID | Modified By | Modified On | Title |
|---|---|---|---|
| 30006888 | Kirby Schwartzbauer | 2026-03-20 13:54:17.098 | Intravenous Immune Globulin Items & Services (IVIGs) |
| 30014696 | Kirby Schwartzbauer | 2026-03-24 13:13:43.813 | CMS Releases Updated Advance Beneficiary Notice of Non-coverage (ABN) |
| 30019642 | James Marko | 2026-03-25 14:29:47.202 | Post Market Studies and Post Market Extension Studies - Percutaneous Transluminal Angioplasty (PTA) with Carotid Stenting and Embolic Protection |
| 30014708 | Kirby Schwartzbauer | 2026-03-24 13:14:27.275 | CMS Releases Updated Advance Beneficiary Notice of Non-coverage (ABN) |
| 30019659 | James Marko | 2026-03-25 14:30:05.46 | Post Market Studies and Post Market Extension Studies - Percutaneous Transluminal Angioplasty (PTA) with Carotid Stenting and Embolic Protection |
| 30019386 | James Marko | 2026-03-25 14:25:14.674 | Healthcare Common Procedure Coding System (HCPCS) Level II Code Compliance Guidance |
| 30019485 | James Marko | 2026-03-25 14:26:53.806 | Billing and Coding Nusinersen, (brand name SPINRAZA®) |
| 30006876 | Kirby Schwartzbauer | 2026-03-20 13:54:10.156 | Intravenous Immune Globulin Items & Services (IVIGs) |
| 30019402 | James Marko | 2026-03-25 14:25:34.962 | Healthcare Common Procedure Coding System (HCPCS) Level II Code Compliance Guidance |
| 30019434 | James Marko | 2026-03-25 14:26:27.269 | Billing and Coding Nusinersen, (brand name SPINRAZA®) |
| Article ID | Modified By | Modified On | Title |
|---|---|---|---|
| 30014672 | Kirby Schwartzbauer | 2026-03-24 13:13:34.198 | CMS Releases Updated Advance Beneficiary Notice (ABN) |
